i-Base home
Search Menu
  • Home
  • HTB
  • 2021
  • November

HTB

November 2021

Contents

Editorial

  • HTB: no. 11 – plus HIV and COVID-19 (Nov/Dec 2021)
  • IAS review on HIV cure research: A global scientific strategy to cure HIV (2021)

Conference reports

  • 18th International European AIDS Conference (EACS 2021)
  • Lenacapavir: drug resistance after viral rebound in treatment experienced participants
  • Implications of historical M184V on use of dual dolutegravir/lamivudine ART
  • Stopping long-acting cabotegravir/rilpivirine: 1 in 5 trial participants didn’t restart oral ART within eight weeks
  • Islatravir plus doravirine dual ART: 144 week follow-up from phase 2 study
  • HIV-specific mental health services across the EU

Antiretrovirals

  • NICE approves long-acting cabotegravir and rilpivirine injections in England and Wales
  • MSD/Merck stop once-weekly NNRTI MK-8507: islatravir studies continue with closer monitoring

Other news

  • UK oral history project for young people who were born with HIV

COVID-19: investigational drugs

  • Colchicine: no clinical benefits against COVID-19 in pooled analysis of RCTs
  • Eli Lilly withdraw EU application for bNAbs etesevimab and bamlanivimab

PDFs

  • HTB: no. 11 – plus HIV and COVID-19 (30 November 2021)
  • HTB RSS

Early access

  • 56 Dean Street as a nurse-led PrEP clinic: >20,000 clients in 2021 27 January 2023
  • Phase 3 Mosaico HIV vaccine efficacy trial stopped early due to lack of benefit 27 January 2023
  • Latest statistics on HIV in the UK: data for 2021 1 December 2022
  • All early access reports

Current issues

  • January 2023
  • December 2022
  • October 2022
  • Back issues

Special report

  • Latest statistics on HIV in the UK: data for 2021 1 December 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook